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Abstract
The aA-crystallin promoter was used to target expression of bone morphogenetic protein 7 (BMP7) to lens ﬁber cells in
transgenic mice. Surprisingly, lens-speciﬁc expression of BMP7 induced widespread apoptosis and rapid ablation of the neural retina
in multiple families. Subsequent to retinal ablation, the lens bow region shifted posteriorly until lens epithelial cells completely
enveloped the lens. Lens-speciﬁc expression of FGF3 was found to rescue the loss of ﬁber cell diﬀerentiation. Our results show that
elevated BMP7 levels can induce rapid retinal degeneration accompanied by disruption of the endogenous ocular system for ﬁber
cell induction.  2002 Elsevier Science Ltd. All rights reserved.
Keywords: Bone morphogenetic proteins; Retinal apoptosis; Lens; Transgenic; Mouse
1. Introduction
Lens formation is a classic example of embryonic
induction (Graw, 1996; Wride, 1996). During early eye
development, the optic vesicle (which later diﬀerentiates
into the retina) is needed for lens placode formation.
Bone morphogenetic proteins (BMPs), secreted proteins
belonging to the TGF-b superfamily, appear to be nec-
essary for the initial morphogenetic events of lens for-
mation (Dudley, Lyons, & Robertson, 1995; Luo et al.,
1995; Furuta & Hogan, 1998; Wawersik et al., 1999).
Following lens induction, the lens placode invaginates,
forms a hollow lens vesicle, and receives a diﬀerentiation
signal from the vitreous that converts the posterior lens
epithelial cells into primary ﬁber cells. Lens epithelial
cells facing the aqueous humor continue to proliferate
and consequently are displaced toward the lens equator
where they encounter the lens ﬁber diﬀerentiation sig-
nal(s) and are induced to form secondary ﬁber cells
(McAvoy, Chamberlain, de Iongh, Hales, & Lovicu,
1999).
Studies suggest that the retina provides the diﬀeren-
tiation signal(s). When chicken lenses were rotated 180,
the epithelial cells facing the vitreous humor began to
diﬀerentiate while the ﬁber cells facing the aqueous
humor stopped elongating (Coulombre & Coulombre,
1963). Surgical removal of the retina from the frog
(Sokolova, Farberov, & Popov, 1970) and mouse
(Yamamoto, 1976) resulted in loss of lens ﬁber diﬀer-
entiation. Furthermore, treatment of rat lens epithelial
cell explants with retinal extracts caused the lens cells to
elongate and to express markers for diﬀerentiated lens
ﬁber cells (McAvoy & Fernon, 1984).
To investigate possible roles of BMPs in ocular sig-
naling after lens induction, transgenic mice expressing
BMP7 speciﬁcally in the lens were generated. Changes in
ocular development and levels of transgene expression
were examined. The mice with the highest levels of
BMP7 expression showed extensive apoptosis through-
out the neural retina beginning shortly after the onset
of transgene expression. This led to rapid, prenatal de-
generation of the neural retina, followed by progressive
posteriorization of the zone of diﬀerentiation in the lens.
In order to test whether the delay in ﬁber cell induction
was due to loss of the ability of the lens cells to respond
to extracellular inductive signals, the BMP7 mice were
mated to mice expressing ﬁbroblast growth factor 3
(FGF3) in the lens. FGF family members are eﬀective
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at inducing lens ﬁber diﬀerentiation in explant culture
systems as well as in transgenic mice (McAvoy, Cham-
berlain, de Iongh, Richardson, & Lovicu, 1991; Robin-
son et al., 1995a; Lovicu & Overbeek, 1998). FGF3 was
not able to rescue or inhibit the retinal degeneration, but
it did induce ﬁber cell diﬀerentiation even in the presence
of BMP7.
2. Methods
2.1. DNA constructs
Human BMP7 cDNA plasmid pcBMP7 (obtained
from Dr. G. Karsenty, Baylor College of Medicine) was
cut with HindIII and XbaI releasing the cDNA frag-
ment plus ﬂanking 50 and the 30b globin noncoding se-
quences. This fragment was ﬁrst inserted into pUC19,
then reisolated as a HindIII/XmaI fragment that was
ligated to a HindIII/XmaI digest of the aA-crystallin
promoter vector 2 (CPV2) (Reneker, Silversides, Patel,
& Overbeek, 1995) to make the CPV2-hBMP7 con-
struct. The cDNA is inserted between the promoter and
the splicing/polyadenylation signals from the early re-
gion of SV40 virus (Fig. 1).
2.2. Generation of transgenic mice
The CPV2-hBMP7 construct was digested with NotI,
bands were separated by agarose gel electrophoresis,
and the microinjection fragment was cut out and puri-
ﬁed using a QiaexII gel extraction kit (Qiagen, Hilden,
Germany). The injection fragment (2.8 kb) was eluted in
10 mM tris-HCl, pH 7.4, 0.1 mM EDTA and diluted to
a ﬁnal concentration of 2 ng/ll. The pronuclei of single
cell stage FVB/N embryos were microinjected as
described (Taketo et al., 1991). Transgenic mice were
identiﬁed by polymerase chain reaction (PCR) using a
protocol provided by Dr. Gary Truett. Tails were boiled
in 25 mM NaOH/0.2 mM EDTA for 20 min to release
the genomic DNA into solution, then neutralized in 40
mM tris-HCl, pH 5 (Truett et al., 2000). SV40 sense and
antisense primers were used for the PCR ampliﬁcations
(Lovicu & Overbeek, 1998).
2.3. Histology
Female FVB/N mice (5–6 weeks old) were superov-
ulated and mated to transgenic or nontransgenic males
to establish timed pregnancies. Embryos were delivered
by Caesarean sections and were screened by PCR (see
above). Embryonic heads (or postnatal eyes) were ﬁxed
in 10% phosphate buﬀered formalin for one to two days
with shaking at room temperature. The tissues were then
transferred to 70% ethanol, dehydrated, paraﬃn em-
bedded, and 5 lm thick sections were cut. Histochemical
staining was done using haematoxylin and eosin.
2.4. In situ hybridization
Transcripts containing SV40, BMP7, Msx2, Id1, or
p57 sequences were detected using [35S] UTP labeled
riboprobes as described previously (Robinson et al.,
1995a). The 0.3 kb SV40 probe was synthesized using
EcoRI digestion and T3 RNA polymerase (Promega)
for the antisense probe and HindIII digestion plus T7
RNA polymerase (Promega) for the sense probe. The
antisense and sense probes for mouse BMP7 were gene-
rated from plasmid BMP7-73 (Genetics Institute). A
fragment of the mouse Msx2 cDNA (provided by Dr. R.
Maas) was cloned into Bluescript KS. An antisense
probe was made following BamHI digestion and tran-
scription using the T7 promoter. Id1 cDNA was ob-
tained via reverse transcriptase (RT)-PCR from 3 week
Fig. 1. Microinjection construct. Schematic drawing of the CPV2-BMP7 construct. A human BMP7 cDNA (hBMP7) of about 1.5 kb ﬂanked by
b-globin non-translated sequences was subcloned into the CPV2 plasmid, between the aA-crystallin promoter (aAp; Reneker et al., 1995) and SV40
sequences containing an intron and a polyadenylation (pA) sequence from small t antigen. Primers SV40A and SV40B, which ﬂank the intron were
used to screen genomic tail DNA via PCR. The SV40 sequence was used to generate a riboprobe for in situ hybridization.
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old mouse eyes using the sense oligo 50-CCGGAA-
TTCTGCAGCTGGAGCTGAACTC-30 and the anti-
sense oligo 50-CGCTCTAGAGAAGGGCTGGAGTC-
CATCTG-30. The PCR product (190 bp) was cloned
into Bluescript KS and used to make an antisense probe
capable of detecting both Id1a and Id1b transcripts. An
antisense p57 riboprobe was made using a mouse p57
cDNA plasmid provided by Dr. S. Elledge (Baylor
College of Medicine). Hybridizations were done on 5 lm
thick ocular sections and were exposed to photographic
emulsion for 6–10 days before developing and haema-
toxylin counterstaining. In some cases, the images were
manipulated in Adobe Photoshop so that the silver
grains seen under dark-ﬁeld illumination are pseudo-
colored red and combined with the corresponding
bright-ﬁeld images.
2.5. Apoptosis
Terminal transferase-mediated dUTP nick-end la-
beling (TUNEL) was used to detect DNA fragmenta-
tion associated with apoptosis. Samples were treated
with 40 lg/ml of Proteinase K for 15 min at room tem-
perature, quenched in methanol/hydrogen peroxide and
labeled with 1 nmol of biotin-16-dUTP (Boehringer
Mannheim) using 50 U of terminal deoxynucleotidyl
transferase (Gibco). Detection of biotin labeled tissue
was via the ABC and 3,30-diaminiobenzidine (DAB)
methods mentioned below. The sections were counter-
stained brieﬂy with methyl green.
2.6. Immunohistochemistry
An antibody against human BMP7 was used for
immunohistochemistry. Sections through embryonic and
postnatal eyes were ﬁrst blocked with 10% normal horse
serum in PBS for 1 h to decrease nonspeciﬁc antibody
interactions. This same solution was used to dilute the
antibodies. Endogenous peroxidase activity was blocked
using 3% H2O2 in 10% methanol. Monoclonal hBMP7
antibody (Genetics Institute h1b5/1.8.5) was used at
a dilution of 1:200. After rinsing in phosphate buﬀer
saline (PBS), biotinylated anti-mouse IgG antibody was
applied. Detection was via incubation with avidinDH,
biotinylated horseradish peroxidase reagent (Vectastain
ABC kit, Vector Laboratories) and DAB to give a
brown stain.
To identify cells in S-phase, 100 lg/g of body weight
of 5-bromo-20-deoxyuridine (BrdU) was injected intra-
peritoneally in postnatal or pregnant mice along with 10
lg/g of body weight of 5-ﬂuoro-20-deoxyuridine (to in-
hibit endogenous thymidine synthesis) in PBS as previ-
ously described (Fromm, Shawlot, Gunning, Butel, &
Overbeek, 1994). 1–2 h following injection, tissues were
harvested, ﬁxed in 10% formalin, dehydrated, and em-
bedded in paraﬃn. 5 lm sections were cut, and endo-
genous peroxidase activity was blocked as indicated
above. The sections were next digested with 0.02%
pepsin for 20 min at 37 C, then treated with 2 N HCl.
After neutralization using 0.1 M sodium borate, pH 8.5,
the slides were incubated in PBS supplemented with
normal horse serum. Monoclonal anti-BrdU antibody
(Dako, Carpinteria, CA) was applied at 1:60 followed
by biotinylated antibody against mouse-IgG (Vector
Laboratories, Inc.). Avidin–biotinHRP complex was ap-
plied using the Vectastain ABC kit as mentioned above,
and detected using DAB.
2.7. Generating double transgenic mice
Double transgenic mice were generated by mating
CPV2-FGF3 mice (family OVE391A) (Robinson et al.,
1998) to CPV2-BMP7 mice (family OVE1340A). The
BMP7 transgene was detected by PCR ampliﬁcation
using a sense primer toward the 30 end of the human
BMP7 cDNA, 50-CGGGCCTGTGGCTGCCACTAG-
30, and an antisense SV40 primer (SV40B, see Fig. 1) to
give a 0.6 kb band. PCR ampliﬁcation was done for 35
cycles under the following conditions: denaturation 30 s
at 94 C, annealing 45 s at 58 C, and extension for 2
min at 72 C. A ﬁnal 10-min extension was done at 72
C. The FGF3 transgene was detected by PCR ampli-
ﬁcation using sense primer CR2 and antisense primer
F4 (Robinson et al., 1998). These primers span a portion
of the aA-crystallin promoter and the FGF-3 gene
respectively, giving a 340 bp band.
3. Results
3.1. Endogenous BMP7 expression
Previous studies on BMP7 knockout mice showed
that BMP7 is variably required for lens induction
(Dudley et al., 1995; Luo et al., 1995; Wawersik et al.,
1999). However, these studies did not provide informa-
tion about possible later roles for BMP7, so we used
in situ hybridizations to assess the pattern of BMP7 ex-
pression in the eye at embryonic day 12.5 (E12.5), E15.5,
and postnatal day 1 (P1). In E12.5 and E15.5 eyes, ex-
pression was detected in the perioptic mesenchyme,
retinal pigmented epithelium (RPE), presumptive cor-
nea, epithelial cells of the lens, and anterior margins of
the retina (Fig. 2A and B). At E12.5, the hyaloid vas-
culature also expressed BMP7 (Fig. 2A). By P1, ex-
pression was most prominent in the developing ciliary
body, iris, and lens epithelial cells, but had disappeared
from the RPE (Fig. 2C). Antisense probes for BMP
receptors IA and II revealed that expression of these
receptors is ubiquitous in the eye from E11.5 to P1 (data
not shown).
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3.2. Generation of transgenic mice
To alter the pattern of BMP7 expression in the eye,
transgenic mice expressing the human BMP7 cDNA
driven by the lens-speciﬁc aA-crystallin promoter were
generated. This promoter has been shown to target
transgene expression to the lens ﬁber cells (Reneker
et al., 1995; Robinson et al., 1995a). Potential founder
mice were screened by PCR using SV40 primers
(SV40A, SV40B) (Fig. 1). Eight transgenic founder mice
were identiﬁed and used to establish families OVE1257,
1258, 1340A, 1340B, 1342A, 1342B, 1343, 1344, and
1345 by matings to nontransgenic FVB/N partners. The
families with the most severe ocular changes were
OVE1340A, 1342A, and 1343 which all showed dra-
matic retinal ablation by E15.5 (Table 1; Fig. 3B).
Transgenic mice in families OVE1342B and 1344 be-
came microphthalmic in the homozygous state, indi-
cating a gene dosage eﬀect (data not shown). Transgenic
mice in families OVE1258 and 1345 showed no appa-
rent ocular defects (see Table 1), and mice in family
OVE1257 developed cataracts as adults (data not
shown). Mice expressing human BMP2 (OVE1202A,
1203) or human BMP4 (OVE1173, 1174) were made in
a similar manner, but none showed any obvious ocular
defects except for adult cataracts (data not shown).
3.3. Transgene expression
To assess transgene expression, in situ hybridizations
were performed using an 35S-labelled SV40 riboprobe
(indicated in Fig. 1). Transgenic transcripts were de-
tected only in the ﬁber cells of the lens (Fig. 3A–H),
consistent with previous transgenic studies using the
same promoter (Reneker et al., 1995; Robinson et al.,
1995a). The levels of transgene expression corresponded
with the severity of the phenotypes (Table 1; Fig. 3).
Families OVE1340A and 1340B showed the highest
levels of expression in conjunction with retinal ablation
by E15.5 (Fig. 3A–D). Families OVE1342B and 1258
showed modest or low transgene expression and later
onset of ocular changes (Fig. 3E–H). Transgene ex-
pression in family OVE1340A at E15.5 was compared
to endogenous BMP7 expression using an antisense
mouse BMP7 riboprobe that also cross-hybridizes to
the transgenic human transcript. Transgene expression
in the lens ﬁber cells was considerably higher than
the endogenous ocular expression of BMP7 (compare
Fig. 3I and J).
A monoclonal antibody against human BMP7 was
used to assess whether transgenic BMP7 protein was be-
ing synthesized in the mouse lens. Transgenic mouse lens
ﬁber cells stained positive for the human BMP7 protein
compared to undetectable staining in the control (Fig. 3K
and L). The intensity of lens staining increased in accor-
dance with the severity of the phenotype (data not
shown). The stainingwas strongest in the lens andwas less
apparent in the surrounding ocular space (Fig. 3K).
To gather more evidence for BMP7 activity outside
the lens, we assayed for changes in expression of Msx1,
Msx2, Id1, and L1 (Marazzi, Wang, & Sassoon, 1997;
Hollnagel, Oehlmann, Heymer, Ruther, & Nordheim,
1999; Perides, Safran, Downing, & Charness, 1994),
Fig. 2. Endogenous BMP7 expression. Expression of BMP7 was assayed by in situ hybridization using an 35S-labelled antisense probe. (A) In the
nontransgenic eye at E12.5, BMP7 transcripts were detected in the lens (l) epithelial cells (e), retinal anterior margins (ar), hyaloid vasculature (hv),
presumptive cornea (c), RPE (rpe), and the ocular mesenchyme (om). (B) By E15.5, BMP7 was still expressed in the lens epithelium, anterior margins
of the retina, and the RPE. (C) At P1, expression was largely conﬁned to the ciliary body (cb), iris (i), and the lens epithelial cells. (B,C) The red haze
over the lens ﬁber cells is an optical artifact; scale bar 100 lm.
Table 1
BMP7 eye phenotypes and levels of transgene expression
Family Eye phenotype
at E15.5
Adult eye size Transgene
expression
1257 Normal Normal þ=
1258 Normal Normal þ=
1340A Retinal ablation Microphthalmia þþþ
1340B Moderate retinal
apoptosis
Small þþþ
1342A Retinal ablation Microphthalmia þþþ
1342B Normal Small þþ
1343 Retinal ablation Microphthalmia þþþ
1344 Normal Small þþ
1345 Normal Normal þ=
Transgene expression was assayed by in situ hybridization. Symbols:
þ=, very weak expression; þþ, moderate expression; þþþ, strong
expression.
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genes known to be downstream targets of BMP signal-
ing in other systems. Antisense probes for each were
used for in situ hybridizations on family OVE1340A. At
E13.5, the transgenic cornea, neural retina, and lens
epithelium showed an increase in Msx2 transcripts re-
lative to the nontransgenic control (Fig. 4A and B).
Msx1 expression remained unchanged at the same age
(data not shown). Id1 transcripts also appeared to be
upregulated in the transgenic retina and lens at E13.5
(Fig. 4C and D). The apparent increase in expression
in the retina may reﬂect preferential survival of Id1 ex-
pressing retinoblasts, rather than an actual elevation in
the levels of transcription per cell. Transcripts of L1, a
neural cell adhesion molecule upregulated in response
to BMPs (Perides et al., 1994), were also enhanced in
OVE1340A eyes at E15.5 (data not shown). The changes
in Msx2, Id1, and L1 expression indicate that multiple
cell types in the eye respond to BMP signaling and that
the transgenic BMP7 protein is being secreted at bio-
logically active levels.
3.4. Retinal apoptosis
The most dramatic phenotype in the transgenic eyes
was the neurodegeneration in the embyronic retina.
Condensed and fragmented nuclei were seen in the ret-
inas of family OVE1340A as early as E13.5 (Fig. 5A and
C). Morphological signs of apoptosis were not detected
at this age in nontransgenic eyes (Fig. 5B and D). To
assay for cell death at the molecular level, TUNEL
assays were performed. TUNEL positive cells (stained
brown) were prevalent in transgenic retinas at E13.5
(Fig. 5E and G), but were not seen in the nontransgenic
control eyes (Fig. 5F and H). Since the aA-crystallin
promoter ﬁrst becomes active around E11.5 (Lovicu &
Overbeek, 1998), these results indicate that the retino-
blasts respond quickly to the transgene, suggesting that
the BMP7 may be directly, rather than indirectly, in-
ducing the apoptosis.
3.5. Lens epithelial cell posteriorization correlates with
retinal ablation
To analyze othermorphological changes, a time course
of the ocular changes in family OVE1340A was estab-
lished (Fig. 6). At E12.5, transgene expressionwas present
in the lens ﬁber cells (data not shown), but the retinal
histology was essentially normal (Fig. 6A). By E15.5, the
neural retina was almost entirely ablated, leaving only a
few disorganized cells in the posterior of the eye (Fig. 6C).
By E17.5, the position of the transition zone (where lens
epithelial cells are induced to become ﬁber cells) had
begun to move posteriorly (Fig. 6E, arrowheads). By P1,
lens epithelial cells surrounded the entire lens (see Fig. 7).
Family OVE1340B at P1 shows a less complete retinal
degeneration (Fig. 6G). In this family, the transition zone
remained at equatorial region (Fig. 6G, arrowheads) sug-
gesting that the partially ablated retina continues to
contribute lens diﬀerentiation signals.
Fig. 3. Transgene expression in CPV2-BMP7 families. In situ hy-
bridizations (A)–(H) were done with an 35S-labelled SV40 riboprobe.
Dark-ﬁeld microscopy for families: (A) OVE1340A, (C) 1340B, (E)
1342B, and (G) 1258 shows that transgene expression is ﬁber cell
speciﬁc at E15.5. The corresponding bright-ﬁeld images show the ex-
tensive retinal degeneration in: (B) OVE1340A and (D) 1340B but not
(F) 1342B or (H) 1258. BMP7 expression was also assayed using
an 35S-labelled antisense mouse BMP7 probe hybridized to: (I)
OVE1340A and (J) nontransgenic eyes at E15.5. The probe detects
both the endogenous mouse BMP7 and the transgenic human BMP7
transcripts. The transgenic transcript is present at a signiﬁcantly higher
level than the endogenous transcript in the lens. Immunohistochemical
staining using a human BMP7 antibody shows staining at E14.5 in the
lens ﬁber cells of OVE1340A eyes (K) while the nontransgenic eye at
E14.5 reveals no staining (L); scale bar 100 lm. Abbreviation: e, lens
epithelial cells; f, lens ﬁber cells; l, lens; r, retina.
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3.6. Molecular evidence for changes in the lens
To conﬁrm that lens diﬀerentiation is aﬀected in the
CPV2-BMP7 transgenic mice, markers for lens diﬀer-
entiation were examined. The region of transcription of
the cyclin-dependent kinase inhibitor p57, a marker for
the onset of ﬁber cell diﬀerentiation (Zhang, Wong,
DePinho, Harper, & Elledge, 1998), was clearly poster-
iorized in the transgenic mice at E17.5 (Fig. 7A, ar-
rowheads) and P1 (Fig. 7C arrowheads). The region of
p57 upregulation remains at the equatorial zone in
nontransgenic eyes (Fig. 7B and D). The fact that p57
expression is still upregulated at the posterior of the
transgenic lenses suggests that the lens diﬀerentiation
signals persist for a few days after retinal ablation. Im-
munohistochemical assays for b-crystallin, a marker for
lens ﬁber cells, also showed an invasion of lens epithelial
cells posteriorly (data not shown), supporting the idea
that the bow region moves posteriorly and that there is
a gradual loss of lens diﬀerentiation.
BrdU assays for cell proliferation were done using
E13.5, E15.5, E17.5, and P1 eyes from OVE1340A and
nontransgenic mice. BrdU-positive epithelial cells were
found anterior and posterior to the equator in trans-
genic E17.5 and P1 sections (Fig. 7E and G, arrow-
heads). In comparison, BrdU stained epithelial cells
exist only in the anterior half of the lens for the non-
transgenic controls (Fig. 7F and H). In both sets of
lenses, only the epithelial cells and not the ﬁber cells
incorporated BrdU. In the transgenic mice, there ap-
pears to be a decrease in proliferation of lens epithelial
cells. At E13.5 three sections each from four transgenic
eyes showed 126:8 8:7 s.d. epithelial cells of which
35:0 2:8% s.d. were in S phase (BrdU positive) com-
pared to 138:7 20:2 s.d. epithelial cells of which
54:5 7:0% s.d. were in S phase for the nontransgenic
controls. The decrease in proliferation at E13.5 may
help explain why the transgenic lenses at E15.5 appear
slightly smaller than nontransgenic lenses. The trend
continues at E17.5 and P1. At P1 an examination of
three sections each from four transgenic eyes showed
190:6 16:5 s.d. epithelial cells of which 4:8 2:1% s.d.
were BrdU positive. In contrast, three sections each
from four nontransgenic eyes showed 228:5 15:0 s.d.
epithelial cells of which 14:8 5:9% s.d. were in S phase.
The decrease in epithelial cell proliferation in combina-
Fig. 4. In situ hybridizations using probes for Msx2 and Id1. Antisense 35S-labelled Msx2 was hybridized to: (A) a nontransgenic and (B) a transgenic
OVE1340A E13.5 eye. Msx2 is normally weakly expressed in the cornea, lens, and anterior retina of nontransgenic eyes (A). In comparison, Msx2
expression was upregulated in the lens epithelial cells, cornea, and neural retina of the transgenic eye (B). Id1 expression was also assessed by in situ
hybridization to: (C) a nontransgenic and (D) a transgenic OVE1340A E13.5 eye. Id1 is expressed in the retina and the cornea of the nontransgenic
eye. In the transgenic eye, the Id hybridization signal was elevated in the neural retina, the RPE, and throughout the lens, scale bar 100 lm.
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tion with the absence of new ﬁber cells may explain the
slowed growth of the transgenic lenses.
3.7. FGF still induces lens diﬀerentiation in CPV2-BMP7
mice
To assess whether the lens epithelial cells in family
OVE1340A can still diﬀerentiate in response to a dif-
ferentiation signal, the mice were crossed to CPV2-
FGF3 mice from family OVE391A. In the OVE391A
mice, expression of FGF3 in the lens induces premature
lens ﬁber cell diﬀerentiation (Robinson et al., 1998). At
E15.5, mice with CPV2-FGF3 alone and the CPV2-
FGF3/CPV2-BMP7 double transgenic mice showed
ﬁber cell induction throughout the lens (Fig. 8A and B).
By E18.5, epithelial cell diﬀerentiation is widespread in
both sets of transgenic mice with some lenses showing
complete epithelial cell diﬀerentiation into ﬁber cells
(Fig. 8C and D). The retinas in the BMP7 transgenic
mice were largely ablated at both ages, indicating that
FGF-3 expression does not interfere with the eﬀects of
BMP7 on the retina. The results also indicate that the
BMP7 expression in the lens does not incapacitate the
ability of the lens cells to respond to a diﬀerentiation
signal.
4. Discussion
The CPV2-BMP7 transgenic mice provide a novel
model system for studies of prenatal retinal degenera-
tion. In the transgenic mice, the levels of transgene
expression (assayed by in situ hybridization and by
immunostaining) correlate with the severity of the reti-
nal ablation. The temporal appearance of retinal apop-
tosis also correlates with that of transgene expression.
Since more than one family shows this phenotype, the
retinal cell death is clearly due to expression of the
BMP7 transgene, rather than the eﬀect of an insertional
mutation at the transgenic integration site. The pheno-
type is accompanied by an increase in Msx2, Id1, and L1
transcripts (all known to be upregulated by exogenously
applied BMP proteins) in multiple ocular tissues, sug-
gesting that the transgenic BMP7 protein is active and
secreted. We also generated analogous CPV2-BMP2 and
CPV2-BMP4 families of mice, but none of these mice
showed retinal defects (data not shown), suggesting that
the neuronal cell death is speciﬁcally induced by BMP7.
Diﬀerential responses to diﬀerent BMPs were previously
described in explants of mouse forebrain neuroectoderm
where BMP2 or BMP4 were more potent in inducing cell
death and Msx1 expression than BMP7 (Furuta, Piston,
Fig. 5. Histological and TUNEL evidence for retinal apoptosis induced by BMP7. E13.5 eye sections from transgenic family OVE1340A (A,C,E,G)
and nontransgenic mice (B,D,F,H) were examined using hematoxylin and eosin staining (A)–(D) and TUNEL (E)–(H). C, D, G and H are high
magniﬁcations of the boxed regions in A, B, E and F, respectively. The transgenic retina showed dark staining pyknotic nuclei (A,C) indicative of
apoptosis. The nontransgenic sections showed no morphological signs of apoptosis (B,D). In support of the morphological ﬁndings, TUNEL positive
cells were present throughout the retina of the transgenic eye (E,G). The nontransgenic control showed no brown TUNEL staining (F,H), scale bar
100 lm (A,B,E,F); 25 lm (C,D,G,H).
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& Hogan, 1997). Other cases in which BMPs have been
shown to cause apoptosis include the interdigital cells of
the limb buds (Zou & Niswander, 1996), neural crest
cells of rhombomeres 3 and 5 (Graham, Francis-West,
Brickell, & Lumsden, 1994), and P19 cells (Marazzi
et al., 1997).
In the most severely aﬀected BMP7 transgenic fami-
lies, the retina begins apoptosis soon after the onset
of transgene expression (Fig. 6A). The death causes a
thinning of the retina, nuclear condensation, and DNA
fragmentation. The process occurs so quickly that only a
small fraction of the neural retina remains at E15.5, and
by P1 the neural retina has disappeared.
Many neurons undergo apoptosis upon p53 activa-
tion in response to DNA fragmentation or inappropri-
ate cell cycle entry (Hughes, Alexi, & Schreiber, 1997).
Fig. 6. Time course of retinal ablation and posterior movement of the lens diﬀerentiation zone. Hematoxylin and eosin stained sections for family
OVE1340A at (A) E12.5, (C) E15.5, and (E) E17.5 were compared to sections from nontransgenic embryos at the same ages (B,D,F). At E15.5, the
transgenic mouse neural retina is almost fully degenerated (C), but the transition zone between lens epithelial and lens ﬁber cells (arrowheads) has not
yet moved posteriorly. At E17.5 the transition zone has begun to move posteriorly (E, arrowheads) and the transgenic lens is signiﬁcantly smaller. In
family OVE1340B at P1, the transition zone (arrowheads) has not posteriorized, even though the neural retina has started to degenerate (G), scale bar
100 lm (A)–(F); 200 lm (G). Abbreviation: r, retina.
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In the OVE1340A mice neither levels of p53 nor p21, a
CDK inhibitor known to be upregulated by active p53
(Harper & Elledge, 1996) were increased, suggesting that
p53 is not involved in the apoptosis (data not shown).
In situ hybridizations for Bcl-xL, a Bcl2 homologue
that protects against apoptosis (Boise et al., 1993), and
for Bax and Bad, two homologues that cause apoptosis
(Oltvai, Milliman, & Korsmeyer, 1993; Yang et al.,
1995) did not reveal signiﬁcant changes in the transgenic
neural retina, indicating that these genes are not the
culprits for the apoptosis (data not shown). One possible
explanation is that the BMP-induced upregulation of
Msx2 or Id is causing the apoptosis, since upregulation
of either one of these genes has been shown to cause
apoptosis in other cell types (Takahashi et al., 1998;
Norton & Atherton, 1998; Tanaka et al., 1998).
At the moment we have not deﬁned the molecular
basis for the BMP7-induced neuronal apoptosis, and
therefore multiple diﬀerent mechanisms warrant con-
sideration. One possibility is inappropriate expression
and/or stimulation of the p75 subunit of the nerve
growth factor receptor (Frade, Rodriguez-Tebar, &
Barde, 1996). Another possibility is that an increase
in intracellular Ca2þ could lead to apoptosis by the
activation of calpain, calmodulin, and/or calcineurin
(McConkey, 1996). Another possibility is that DNA
ligase IV and/or XRCC4 are rendered nonfunctional
(Chun & Schatz, 1999) so that if DNA rearrangements
Fig. 7. p57 and BrdU changes. Transgenic OVE1340A (A,C) and non-transgenic (B,D) mouse eye sections were analyzed by in situ hybridization for
p57 expression. While p57 expression is induced upon ﬁber cell initiation at the equatorial region of nontransgenic lenses at E17.5 (B, arrowheads)
and P1 (D), the onset of p57 expression is moved posteriorly in the transgenic lenses at E17.5 (A, arrowheads) and P1 (C, arrowheads). BrdU
incorporation (brown staining), which indicates cells in S phase, was also assayed (E)–(H). There is a general decrease in the proliferation of lens
epithelial cells in the transgenic family (E,G) compared to the nontransgenic mice (F,H). At E17.5 (E) and P1 (G) the arrowheads indicate pro-
liferating epithelial cells in the posterior part of the transgenic lens, scale bar 100 lm (A–C, E–H); 200 lm (D).
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occur as a part of retinal development, apoptosis may
occur due to the inability to repair these breaks. Casp-
ases may also play a part in this apoptosis. At the
moment it seems unlikely that the apoptosis is due to
the lack of appropriate neurotrophic factor stimulation,
since the retinal apoptosis begins when the neuronal
cells are still immature and presumably do not yet re-
quire neurotrophic factors for survival.
Despite the retinal ablation by E15.5 in OVE1340A
mice, it is not until E17.5 that the bow region of the
lens begins to move posteriorly. It may be that the lens
receives a lingering diﬀerentiation signal synthesized
earlier by the retina or produced by the small patch of
remaining retina. In frogs a similar lens epithelial cell
posteriorization did not occur until a few days after
retina removal (Sokolova et al., 1970). In addition, the
lens diﬀerentiation signal may have an extended life
span in the heparin sulfate rich environment of the
vitreous (Tsen, Halfter, Kroger, & Cole, 1995). For
example, FGFs are known to be able to induce ﬁber
cell diﬀerentiation (McAvoy et al., 1991) and to be
stabilized by binding to heparin sulfate (Klagsbrun,
1992). The patterns of p57 and b-crystallin expression
suggest the gradual disappearance of the signal for ﬁber
cell diﬀerentiation subsequent to neural retinal abla-
tion. By P1 the disappearance of the retina is accom-
panied by the complete enclosure of the lens by lens
epithelial cells.
The changes in Msx2 and Id1 transcription in the
transgenic lenses (Fig. 4) show that BMP7 can directly
alter gene expression in the lens. However, since ex-
pression of FGF3 can induce these lens cells to un-
dergo ﬁber cell diﬀerentiation, BMP7 expression does
not incapacitate the ability of the lens cells to diﬀer-
entiate. In addition, if BMP7 were directly responsible
for inhibiting ﬁber cell diﬀerentiation, we would pre-
dict that p57 induction would be completely lost in
the transgenic lenses, rather than being slowly dis-
placed toward the posterior of the lens. The notion
that the eﬀect on the lens is indirect is consistent with
earlier studies (Coulombre & Coulombre, 1963; Ya-
mamoto, 1976) that showed that surgical rotation of
the lens resulted in the loss of ﬁber cell diﬀerentiation
on the side of the lens facing away from the retina
and diﬀerentiation of the lens epithelium to lens ﬁber
cells on the side facing the retina. Nonetheless, at this
Fig. 8. Ocular histology of double transgenic mice (FGF3 and BMP7). Histology sections of E15.5 (A,B) and E18.5 (C,D) eyes of mice expressing
FGF3 (OVE391A) (A,C) or FGF3 and BMP7 (OVE391A/OVE1340A) (B,D) are shown. At E15.5, the CPV2-FGF3 lens shows premature initiation
of ﬁber diﬀerentiation in the lateral epithelial cells (arrow; A) while the double transgenic eye shows a combination of retinal ablation (double arrows)
and premature initiation of ﬁber diﬀerentiation (arrow; B). By E18.5, both the CPV2-FGF3 and the double transgenic mouse eyes show diﬀeren-
tiation of all lens epithelial cells into ﬁber cells (C,D). The diﬀerentiation of the corneal stroma is clearly aﬀected in the FGF3 eye at E15.5 (A), but is
normalized in the double transgenic eye (B), scale bar 100 lm. Abbreviation: c, corneal stroma.
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point in time, we have not established whether the
loss of ﬁber cell diﬀerentiation is due to direct inhi-
bition by BMP or is a consequence of the retinal
apoptosis.
At P1 the transgenic lens is appreciably smaller than
a normal lens. One explanation for the decreased lens
epithelial cell proliferation may be that the synthesis of
proliferation signals such as PDGF-A and PDGF-B
may be reduced or shut oﬀ. Since these two growth
factors are expressed from the ciliary body and iris
(Reneker & Overbeek, 1996), improper development of
these ocular tissues in the CPV2-BMP7 mice may cause
a reduction in synthesis of these signals. It is also pos-
sible that a reduction in the number of ﬁber cells may
cause reduced epithelial cell proliferation. In transgenic
lenses overexpressing a dominant negative FGF recep-
tor, ﬁber cell numbers are reduced by apoptotic death
and there is a concurrent decrease in lens epithelial cell
proliferation (Robinson, MacMillan-Crow, Thompson,
& Overbeek, 1995b).
The FGF3/BMP7 double transgenic allowed us to
assay in vivo for synergistic and/or antagonistic inter-
actions between two diﬀerent, developmentally impor-
tant families of growth factors. FGFs are known to
stimulate FGF receptors, which are tyrosine kinases that
can signal through the ras-raf-MAPK pathway (Mar-
shall, 1995). In contrast, BMP receptors are serine–
threonine kinases that activate Smad1 and Smad5
transcription factors (Kretzschmar & Massague, 1998).
Previous studies have suggested that FGF and BMP
eﬀects on a tissue might be antagonistic. BMPs have
been shown to antagonize the downstream expression of
genes upregulated by FGFs in tooth formation (Neu-
buser, Peters, Balling, & Martin, 1997), maxillary pri-
mordia (Barlow, Bogardi, Ladher, & Francis-West,
1999), and in endochondral hypertrophic chondrocytes
(Terkeltaub et al., 1998). On the other hand, FGFs have
been shown to antagonize the eﬀects of BMPs in the
interdigital membrane (Ganan, Macias, Duterque-
Coquillaud, Ros, & Hurle, 1996) and the limb bud
(Niswander &Martin, 1993). The fact that FGF3/BMP7
double transgenic lenses showed diﬀerentiation of all
lens epithelial cells to ﬁber cells indicates that the FGF3
signal is not, or is only partially, antagonized by BMP7
in the lens. Additionally, the retinal ablation caused by
an excess of BMP7 was not rescued by the FGF3 signal.
However, BMP7 seemed to partially rescue the disrup-
tion in the corneal morphology caused by FGF3 ex-
pression (Fig. 8A and B). The mechanisms for these
tissue-speciﬁc diﬀerences are undeﬁned.
Our study, in combination with the BMP7 knock-
out studies (Dudley et al., 1995; Luo et al., 1995;
Wawersik et al., 1999), suggests that the level of BMP7
expression must fall within a deﬁned range for ocular
development to occur normally. Since overexpression
of BMP7 rapidly induces retinal apoptosis, the CPV2-
BMP7 transgenic mice provide a new system for
studies of programmed cell death during neuronal
development and for analysis of ocular development
after prenatal ablation of the neural retina. In the
future, it will also be important to determine whether
postnatal upregulation of BMP7 can cause retinal de-
generation.
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